[go: up one dir, main page]

BR0010060A - Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica - Google Patents

Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica

Info

Publication number
BR0010060A
BR0010060A BR0010060-9A BR0010060A BR0010060A BR 0010060 A BR0010060 A BR 0010060A BR 0010060 A BR0010060 A BR 0010060A BR 0010060 A BR0010060 A BR 0010060A
Authority
BR
Brazil
Prior art keywords
hydroxy
steroids
methoxymethyl
anesthetic activity
heterocycle replaced
Prior art date
Application number
BR0010060-9A
Other languages
English (en)
Inventor
Derk J Hogenkamp
Original Assignee
Purdue Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Ltd filed Critical Purdue Pharma Ltd
Publication of BR0010060A publication Critical patent/BR0010060A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

"ESTERóIDES 3<244>-HIDROXI-3<225>-METOXIMETIL-21-HETEROCìCLO SUBSTITUìDOS COM ATIVIDADE ANESTéSICA". Essa invenção se refere a compostos possuindo a Fórmula (I) ou um sal farmaceuticamente aceitável, pró-droga ou solvato deles provenientes, onde R~ 1~ é H ou metila; R~ 2~ é 5<244>- ou 5<225>-H; R~ 3~ é um grupo heteroarila N-anexado opcionalmente substituído ou um grupo -X-R~ 4~; R~ 4~ é um grupo heteroarila carbono-anexado opcionalmente substituído; e X é O, S, ou N. A invenção também está direcionada ao uso de esteróides 3<244>-hidroxi-3<225>-metoximetil-substituídos como sedativos/hipnóticos e para induzir anestesia.
BR0010060-9A 1999-04-29 2000-04-28 Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica BR0010060A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13157899P 1999-04-29 1999-04-29
PCT/US2000/011680 WO2000066614A1 (en) 1999-04-29 2000-04-28 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY

Publications (1)

Publication Number Publication Date
BR0010060A true BR0010060A (pt) 2002-01-15

Family

ID=22450073

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010060-9A BR0010060A (pt) 1999-04-29 2000-04-28 Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica

Country Status (20)

Country Link
US (2) US20040034002A1 (pt)
EP (1) EP1177206A1 (pt)
JP (1) JP2002543218A (pt)
KR (1) KR20020013530A (pt)
CN (1) CN1187367C (pt)
AU (1) AU780989B2 (pt)
BR (1) BR0010060A (pt)
CA (1) CA2372342A1 (pt)
CZ (1) CZ20013867A3 (pt)
HU (1) HUP0201818A3 (pt)
IL (1) IL146230A0 (pt)
MX (1) MXPA01010915A (pt)
NO (1) NO321536B1 (pt)
NZ (1) NZ515779A (pt)
PL (1) PL351438A1 (pt)
RU (1) RU2243232C2 (pt)
UA (1) UA73736C2 (pt)
WO (1) WO2000066614A1 (pt)
YU (1) YU77701A (pt)
ZA (1) ZA200109847B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118248A1 (en) * 2004-04-23 2009-05-07 Euro-Celtique S.A. 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof
US20060074059A1 (en) * 2004-08-26 2006-04-06 Goliber Philip A Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one
AU2006256851C1 (en) * 2005-06-09 2010-07-15 Euro-Celtique S.A. Pharmaceutical compositions of a neuroactive steroid and uses thereof
DE102008058436B4 (de) * 2008-11-21 2019-03-07 Osram Opto Semiconductors Gmbh Kantenemittierender Halbleiterlaserchip
AU2012304412A1 (en) 2011-09-08 2014-03-27 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2012323888A1 (en) 2011-10-14 2014-05-29 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
BR112015026380A8 (pt) 2013-04-17 2019-12-31 Sage Therapeutics Inc esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3488852B1 (en) * 2013-08-23 2020-10-28 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
KR20240066304A (ko) * 2014-05-29 2024-05-14 세이지 테라퓨틱스, 인크. 신경활성 스테로이드, 조성물, 및 그의 용도
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2015331597B2 (en) 2014-10-16 2020-04-30 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
CN117024502A (zh) * 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
HRP20210526T8 (hr) 2015-07-06 2021-08-20 Sage Therapeutics, Inc. Oksisteroli i postupci za njihovu uporabu
LT3436022T (lt) 2016-04-01 2022-06-27 Sage Therapeutics, Inc. Oksisteroliai ir jų panaudojimo būdai
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス， インコーポレイテッド Ｃ７、ｃ１２、およびｃ１６置換神経刺激性ステロイドおよびそれらの使用方法
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
ES2935057T3 (es) 2016-09-30 2023-03-01 Sage Therapeutics Inc C7 oxisteroles sustituidos y estos compuestos para su uso como moduladores de la NMDA
TWI772331B (zh) 2016-10-18 2022-08-01 美商賽吉醫療公司 氧固醇(oxysterol)及其使用方法
US10562930B1 (en) * 2018-08-31 2020-02-18 Praxis Precision Medicines, Inc. Salts and crystal forms of GABAA positive allosteric modulator
CA3121636A1 (en) 2018-12-17 2020-06-25 Intra-Cellular Therapies, Inc. Analogs of (3alpha,5alpha)-3-hydroxy-21-(1h-imidazol-1-yl)-3-methoxymethyl)-pregnan-20-one
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc
US20230346801A1 (en) 2020-03-25 2023-11-02 Sage Therapeutics, Inc. Use of agents for treatment of respiratory conditions
JP2023539125A (ja) * 2020-08-20 2023-09-13 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
WO2022177718A1 (en) 2021-02-18 2022-08-25 Sage Therapeutics, Inc. Use of neuroactive steroid for treatment of sexual dysfunction
WO2023159035A1 (en) 2022-02-16 2023-08-24 Sage Therapeutics, Inc. Neuroactive steroids for treatment of cns-related disorders
WO2023159094A2 (en) * 2022-02-16 2023-08-24 Praxis Precision Medicines, Inc. PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE
WO2023164386A1 (en) 2022-02-28 2023-08-31 Sage Therapeutics, Inc. Neuroactive steroids for treatment of gastrointestinal diseases or conditions
WO2024230797A1 (zh) * 2023-05-11 2024-11-14 上海枢境生物科技有限公司 甾体类化合物、制备方法及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969345A (en) * 1970-12-17 1976-07-13 Glaxo Laboratories Limited 20β,21-Epoxy-3α-hydroxy-5α-pregnanes and derivatives thereof
US3943124A (en) * 1970-12-17 1976-03-09 Gordon Hanley Phillipps Chemical compounds
US3953429A (en) * 1970-12-17 1976-04-27 Glaxo Laboratories Limited Anaesthetic steroids of the androstance and pregnane series
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
US3959260A (en) * 1972-05-05 1976-05-25 Glaxo Laboratories Limited Anaesthetic steroids of the pregnane and 19-norpregnane series having a sulfur-containing group at the 21-position
GB1436324A (en) * 1972-05-12 1976-05-19 Glaxo Lab Ltd Anaesthetic 3alpha-hydroxy pregnanes
US4192871A (en) * 1976-01-06 1980-03-11 Glaxo Laboratories Limited Chemical compounds
US4197296A (en) * 1977-03-23 1980-04-08 Glaxo Group Limited Androstanes
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5319115A (en) * 1987-08-25 1994-06-07 Cocensys Inc. Method for making 3α-hydroxy, 3β-substituted-pregnanes
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
WO1995021617A1 (en) * 1994-02-14 1995-08-17 Cocensys, Inc. Androstanes and pregnanes for allosteric modulation of gaba receptor
HUP9901138A3 (en) * 1995-06-06 1999-11-29 Cocensys Inc Irvine Neuroactive steroids of the androstane and pregnane series

Also Published As

Publication number Publication date
AU780989B2 (en) 2005-04-28
KR20020013530A (ko) 2002-02-20
CA2372342A1 (en) 2000-11-09
RU2243232C2 (ru) 2004-12-27
US20040034002A1 (en) 2004-02-19
CN1360591A (zh) 2002-07-24
AU4810400A (en) 2000-11-17
HK1047594A1 (en) 2003-02-28
NZ515779A (en) 2003-11-28
NO20015262L (no) 2001-12-19
NO321536B1 (no) 2006-05-22
IL146230A0 (en) 2002-07-25
NO20015262D0 (no) 2001-10-26
CN1187367C (zh) 2005-02-02
WO2000066614A1 (en) 2000-11-09
WO2000066614A8 (en) 2001-03-15
PL351438A1 (en) 2003-04-22
MXPA01010915A (es) 2002-11-07
JP2002543218A (ja) 2002-12-17
EP1177206A1 (en) 2002-02-06
US20050171074A1 (en) 2005-08-04
ZA200109847B (en) 2003-02-26
HUP0201818A3 (en) 2004-04-28
YU77701A (sh) 2005-07-19
CZ20013867A3 (cs) 2002-07-17
HUP0201818A2 (en) 2002-10-28
UA73736C2 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
BR0010060A (pt) Esteróides 3&lt;244&gt;-hidroxi-3&lt;225&gt;-metoximetil-21-heterocìclo substituìdos com atividade anestésica
BR0111015A (pt) Antagonistas de receptor a2a de adenosina
BR0015843A (pt) Antagonista de y5 para npy
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
TR200100241T2 (tr) Nosiseptin reseptörü ORL-1 için yüksek çekim gücü olan ligandlar
BR0102083A (pt) Uso de derivados de alfa-cetoenamina como ingredientes
JO2503B1 (en) Benzathiazole derivatives
CO5450244A1 (es) Derivados de adenina
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
ECSP066311A (es) Derivados de la piperazina y su uso como agentes terapéuticos
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
BRPI0413232B8 (pt) composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto
HUP0202490A2 (hu) Indazolszármazékok és ezeket tartalmazó protein-kináz gátló hatású gyógyszerkészítmények
DE60114227D1 (de) 2,4-substituierte pyridinderivate
BRPI0606817A2 (pt) derivados de piridazina e seu uso como agentes terapêuticos
SE9904508D0 (sv) New compounds
BR0011850A (pt) Agonistas de receptor a2a de propargil fenil éter
TR200103395T2 (tr) 13-metil eritromisin türevleri.
BR0007229A (pt) Aminoazaciclos heterocìclicos substituìdos úteis como agentes de sistema nervoso central
BR0013014A (pt) Derivados de 6-aza uracila inibindo interleucina-5

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: EURO-CELTIQUE S.A (LU)

Free format text: TRANSFERIDO DE: PURDUE PHARMA LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. E 9A. ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.